GR970300013T1 - Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade - Google Patents

Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade

Info

Publication number
GR970300013T1
GR970300013T1 GR970300013T GR970300013T GR970300013T1 GR 970300013 T1 GR970300013 T1 GR 970300013T1 GR 970300013 T GR970300013 T GR 970300013T GR 970300013 T GR970300013 T GR 970300013T GR 970300013 T1 GR970300013 T1 GR 970300013T1
Authority
GR
Greece
Prior art keywords
ropivacaine
manufacture
pharmaceutical
pct
minimal motor
Prior art date
Application number
GR970300013T
Other languages
Greek (el)
English (en)
Inventor
Arne Torsten Eek
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20390432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR970300013(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Publication of GR970300013T1 publication Critical patent/GR970300013T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Insulation, Fastening Of Motor, Generator Windings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Particle Accelerators (AREA)
  • Air Conditioning Control Device (AREA)
  • Steroid Compounds (AREA)
  • Electromechanical Clocks (AREA)
  • Medicinal Preparation (AREA)
GR970300013T 1993-06-28 1997-05-30 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade GR970300013T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19939302218A SE9302218D0 (sv) 1993-06-28 1993-06-28 New use
PCT/SE1994/000496 WO1995000148A1 (en) 1993-06-28 1994-05-26 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade

Publications (1)

Publication Number Publication Date
GR970300013T1 true GR970300013T1 (en) 1997-05-31

Family

ID=20390432

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970300013T GR970300013T1 (en) 1993-06-28 1997-05-30 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade

Country Status (32)

Country Link
US (2) US5670524A (cg-RX-API-DMAC7.html)
EP (1) EP0706395B1 (cg-RX-API-DMAC7.html)
JP (1) JP3725541B2 (cg-RX-API-DMAC7.html)
CN (1) CN1074918C (cg-RX-API-DMAC7.html)
AT (1) ATE216237T1 (cg-RX-API-DMAC7.html)
BR (1) BR9406865A (cg-RX-API-DMAC7.html)
CA (1) CA2165446C (cg-RX-API-DMAC7.html)
CZ (1) CZ283300B6 (cg-RX-API-DMAC7.html)
DE (2) DE69430427T2 (cg-RX-API-DMAC7.html)
DK (1) DK0706395T3 (cg-RX-API-DMAC7.html)
EE (1) EE03205B1 (cg-RX-API-DMAC7.html)
ES (1) ES2099048T3 (cg-RX-API-DMAC7.html)
FI (1) FI956269A0 (cg-RX-API-DMAC7.html)
GR (1) GR970300013T1 (cg-RX-API-DMAC7.html)
HU (1) HU218949B (cg-RX-API-DMAC7.html)
IL (1) IL110006A (cg-RX-API-DMAC7.html)
IS (1) IS4174A (cg-RX-API-DMAC7.html)
LT (1) LT3449B (cg-RX-API-DMAC7.html)
LV (1) LV12918B (cg-RX-API-DMAC7.html)
MY (1) MY119360A (cg-RX-API-DMAC7.html)
NO (1) NO955313L (cg-RX-API-DMAC7.html)
NZ (1) NZ268110A (cg-RX-API-DMAC7.html)
PH (1) PH31258A (cg-RX-API-DMAC7.html)
PL (1) PL175518B1 (cg-RX-API-DMAC7.html)
PT (1) PT706395E (cg-RX-API-DMAC7.html)
RU (1) RU2152215C1 (cg-RX-API-DMAC7.html)
SA (1) SA94150010B1 (cg-RX-API-DMAC7.html)
SE (1) SE9302218D0 (cg-RX-API-DMAC7.html)
SG (1) SG49078A1 (cg-RX-API-DMAC7.html)
SK (1) SK280111B6 (cg-RX-API-DMAC7.html)
TW (1) TW285640B (cg-RX-API-DMAC7.html)
WO (1) WO1995000148A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use
CA2294950C (en) * 1997-07-21 2009-04-07 Darwin Discovery Limited Levobupivacaine and its use
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
US8920843B2 (en) * 2007-11-07 2014-12-30 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
AU2013257727B2 (en) * 2012-05-10 2016-04-28 Cellixbio Private Limited Compositions and methods for the treatment of local pain
CA2871821C (en) * 2012-05-10 2021-01-12 Painreform Ltd. Depot formulations of a local anesthetic and methods for preparation thereof
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
ES2981043T3 (es) 2013-02-28 2024-10-07 Journey Medical Corp Procedimiento para fabricar tosilato de glicopirrolato treo

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0151110B1 (en) * 1983-08-01 1989-03-01 Astra Läkemedel Aktiebolag L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use

Also Published As

Publication number Publication date
ES2099048T1 (es) 1997-05-16
SK164695A3 (en) 1996-07-03
LV12918B (en) 2003-03-20
US5670524A (en) 1997-09-23
FI956269L (fi) 1995-12-27
SK280111B6 (sk) 1999-08-06
NO955313D0 (no) 1995-12-27
TW285640B (cg-RX-API-DMAC7.html) 1996-09-11
SE9302218D0 (sv) 1993-06-28
WO1995000148A1 (en) 1995-01-05
HK1010344A1 (en) 1999-06-17
DE706395T1 (de) 1997-09-04
CA2165446A1 (en) 1995-01-05
DE69430427D1 (de) 2002-05-23
HU218949B (hu) 2001-01-29
RU2152215C1 (ru) 2000-07-10
CZ336495A3 (en) 1996-06-12
IL110006A (en) 1999-01-26
EP0706395A1 (en) 1996-04-17
DK0706395T3 (da) 2002-07-22
EE03205B1 (et) 1999-08-16
NO955313L (no) 1995-12-27
PL312198A1 (en) 1996-04-01
JPH09500620A (ja) 1997-01-21
FI956269A7 (fi) 1995-12-27
IL110006A0 (en) 1994-11-11
HUT75115A (en) 1997-04-28
ATE216237T1 (de) 2002-05-15
CN1074918C (zh) 2001-11-21
IS4174A (is) 1994-12-29
PT706395E (pt) 2002-09-30
HU9503692D0 (en) 1996-02-28
LT3449B (en) 1995-10-25
AU692161B2 (en) 1998-06-04
JP3725541B2 (ja) 2005-12-14
US5834489A (en) 1998-11-10
DE69430427T2 (de) 2002-11-14
LTIP1958A (en) 1995-01-31
PL175518B1 (pl) 1999-01-29
CN1126435A (zh) 1996-07-10
CA2165446C (en) 2005-07-05
MY119360A (en) 2005-05-31
AU7086694A (en) 1995-01-17
SA94150010B1 (ar) 2006-04-04
FI956269A0 (fi) 1995-12-27
BR9406865A (pt) 1996-03-26
NZ268110A (en) 1999-06-29
PH31258A (en) 1998-06-18
SG49078A1 (en) 1998-05-18
ES2099048T3 (es) 2002-11-16
EP0706395B1 (en) 2002-04-17
CZ283300B6 (cs) 1998-02-18

Similar Documents

Publication Publication Date Title
EG22373A (en) New pharmaceutical formulation
IL113631A0 (en) New antagonist compounds
GR970300013T1 (en) Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
ZA951588B (en) Antitussive composition
IL122853A0 (en) Use of allylamines
HU9502062D0 (en) Application of riluzole as a radiorestorer